Minko and coworkers developed a LHRH targeted poly amidoamine dendrimerpaclitaxel conjugate and showed that LHRH targeted conjugates could be internalized by cancer cells efficiently and reduce the adverse side effects of chemotherapy [20]. The gene discussed is GNRH1; the disease is cancer.